Who
Todd E. Simpson
Director
Company insider
Files Form 4 as: Director, Xencor; Chief Financial Officer, Seagen; Director, Neurogene.
In numbers
- Trades disclosed
- 317
- Buys
- 0
- Sells
- 57
- Bought
- $0
- Sold
- $94.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 31 Jan 2006
- Last trade
- 16 Jun 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —20,604 at $0.00 | filing |
| 16 Jun 2026filed 8 Jul 2026 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —10,302 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —27,372 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | XNCR XencorBiotechnology | SEC FORM 4 Code A | —13,686 at $0.00 | filing |
| 13 Mar 2025filed 13 Mar 2025 | XNCR Xencoroption or derivative · Biotechnology | SEC FORM 4 Code A | —43,337 at $0.00 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —1,301 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —47,904 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —1,333 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —49,232 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —636 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —20,774 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —642 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —26,427 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —10,526 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —2,158 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —5,547 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —11,585 | filing |
| 14 Dec 2023filed 15 Dec 2023 | Seagenoption or derivative | SEC FORM 4 Code D | —1,395 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.